Zhitong Finance App News, Shengda Biotech (603079.SH) announced that the company plans to use its own funds or self-raised funds to repurchase some of the company's issued RMB common stock A shares through centralized bidding transactions. The repurchase of shares is intended to be the source of shares for employee stock ownership plans or equity incentives. The share repurchase amount is not less than 16.5 million yuan (inclusive) and no more than 30 million yuan (inclusive). The share repurchase price is not more than 15 yuan/share (inclusive).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.